Shanghai Haohai Biological Technology Co., Ltd. Class H's market cap is currently HK$13.31B. The company's EPS TTM is HK$1.958; its P/E ratio is 13.48; and it has a dividend yield of 4.65%. Shanghai Haohai Biological Technology Co., Ltd. Class H is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 2.63B	¥ 2.10B	¥ 1.75B	¥ 1.32B	¥ 1.60B
Gross Profit	¥ 1.85B	¥ 1.45B	¥ 1.26B	¥ 990.42M	¥ 1.23B
Operating Income	¥ 438.38M	¥ 258.66M	¥ 384.43M	¥ 260.56M	¥ 437.96M
EBITDA	¥ 713.41M	¥ 447.55M	¥ 550.45M	¥ 394.80M	¥ 554.31M
Net Income	¥ 416.12M	¥ 180.47M	¥ 352.23M	¥ 230.07M	¥ 370.78M
Balance Sheet
Cash & Short-Term Investments	¥ 2.75B	¥ 2.54B	¥ 2.91B	¥ 3.11B	¥ 3.22B
Total Assets	¥ 7.11B	¥ 6.89B	¥ 6.95B	¥ 6.30B	¥ 6.15B
Total Debt	¥ 407.95M	¥ 118.26M	¥ 105.51M	¥ 108.08M	¥ 49.71M
Net Debt	¥ -2.33B	¥ -2.42B	¥ -2.80B	¥ -2.98B	¥ -3.17B
Total Liabilities	¥ 1.09B	¥ 990.02M	¥ 890.07M	¥ 564.46M	¥ 498.52M
Stockholders' Equity	¥ 5.65B	¥ 5.51B	¥ 5.71B	¥ 5.49B	¥ 5.45B
Cash Flow
Free Cash Flow	¥ 367.22M	¥ -85.85M	¥ 70.19M	¥ 66.21M	¥ -50.39M
Operating Cash Flow	¥ 634.45M	¥ 231.30M	¥ 342.29M	¥ 262.07M	¥ 348.91M
Investing Cash Flow	¥ -376.65M	¥ -681.82M	¥ -148.09M	¥ 316.92M	¥ -1.14B
Financing Cash Flow	¥ -257.73M	¥ -288.35M	¥ -231.25M	¥ -190.06M	¥ 1.39B

Currency in CNY

Shanghai Haohai Biological Technology Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Shanghai Haohai Biological Technology Co., Ltd. Class H Debt to Assets

Balance Sheet >

Shanghai Haohai Biological Technology Co., Ltd. Class H Cash Flow

Cash Flow >

Shanghai Haohai Biological Technology Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing